Knockdown of DLX6-AS1 suppressed the growth and invasive abilities of cancer cells by disrupting the epithelial–mesenchymal transition program in gastric cancer [11,27] and esophageal squamous cell carcinoma [28]. Here, DLX6 is linked to esophageal squamous cell carcinoma.